Literature DB >> 26198545

Influence of patient medication information format on comprehension and application of medication information: A randomized, controlled experiment.

Vanessa Boudewyns1, Amie C O'Donoghue2, Bridget Kelly3, Suzanne L West3, Oluwamurewa Oguntimein2, Carla M Bann3, Lauren A McCormack3.   

Abstract

OBJECTIVE: To examine patients' comprehension and application of alternative versions of patient medication information handouts for a fictitious drug, and whether patient characteristics influence patients' ability to understand the handouts.
METHODS: A web-based experiment was conducted in which 1397 adults with rheumatoid arthritis, ankylosing spondylitis, or plaque psoriasis were randomly assigned to one of three conditions: (1) a one-page "Bubbles" format; (2) a one-page "Over-The-Counter" (OTC) format; and (3) a four-page document modeled after MedGuides used in 2009 which served as the control arm. Comprehension and application of information in the handouts were the key outcomes of interest.
RESULTS: Participants who viewed either the Bubbles or OTC formats had greater comprehension than participants who viewed the MedGuide, but did not have better application scores. No significant differences were noted between the Bubbles and OTC formats. Patient characteristics did not moderate the results.
CONCLUSION: Both formats resulted in better comprehension than the MedGuide format used in the study. PRACTICE IMPLICATIONS: Results provide valuable information on how to design patient information to improve patients' understanding of the risks and benefits of the drugs they are prescribed. Results could be extended to inform the content of other types of patient education materials.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Year:  2015        PMID: 26198545     DOI: 10.1016/j.pec.2015.07.003

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  8 in total

1.  Capsule Commentary on Wolf et al., A Patient-Centered Prescription Drug Label to Promote Appropriate Medication Use and Adherence.

Authors:  Fabrice Smieliauskas
Journal:  J Gen Intern Med       Date:  2016-12       Impact factor: 5.128

2.  A Multi-faceted Approach to Promote Comprehension of Online Health Information Among Older Adults.

Authors:  Jessie Chin; Darcie D Moeller; Jessica Johnson; Elise A G Duwe; James F Graumlich; Michael D Murray; Daniel G Morrow
Journal:  Gerontologist       Date:  2018-07-13

Review 3.  Medication Risk Communication in Rheumatology: Where Are We and Where Do We Go from Here?

Authors:  Susan J Blalock
Journal:  Curr Rheumatol Rep       Date:  2017-02       Impact factor: 4.592

4.  Placement and Format of Risk Information on Direct-to-Consumer Prescription Drug Websites.

Authors:  Helen W Sullivan; Amie C O'Donoghue; Douglas J Rupert; Jessica Fitts Willoughby; Kathryn J Aikin
Journal:  J Health Commun       Date:  2017-01-27

5.  Health Literacy Level and Comprehension of Prescription and Nonprescription Drug Information.

Authors:  Meehoh Kim; David Suh; Joseph A Barone; Sun-Young Jung; Wenchen Wu; Dong-Churl Suh
Journal:  Int J Environ Res Public Health       Date:  2022-05-30       Impact factor: 4.614

6.  Role of Information Anxiety and Information Load on Processing of Prescription Drug Information Leaflets.

Authors:  Shweta S Bapat; Harshali K Patel; Sujit S Sansgiry
Journal:  Pharmacy (Basel)       Date:  2017-10-16

7.  Effects of additional context information in prescription drug information sheets on comprehension and risk and efficacy perceptions.

Authors:  Bridget Kelly; Amie O'Donoghue; Sarah Parvanta; Vanessa Boudewyns; Oluwamurewa Oguntimein; Carla Bann; Sue West; Janice Tzeng; Caroline Chandler; Gabriel Madson; Lauren McCormack
Journal:  J Pharm Policy Pract       Date:  2022-03-01

8.  Refining Prescription Warning Labels Using Patient Feedback: A Qualitative Study.

Authors:  Olayinka O Shiyanbola; Paul D Smith; Sonal Ghura Mansukhani; Yen-Ming Huang
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.